Lisa Yerian, MD
Liver Pathology
Highlights
Age Groups Seen
- Adult
Languages
- English
Gender
FemaleAbout Lisa Yerian
Title
Executive Vice President and Chief Clinical and Operational Improvement Officer
Biography
Previously, Dr. Yerian was Chief Improvement Officer at Cleveland Clinic before becoming the Clinic’s Interim Chief Clinical Transformation Officer in July 2023. She has also served as Director of Liver Pathology and Section Head of Surgical Pathology at Cleveland Clinic and is a former member of the Board of Governors and Vice Chair of Professional Staff Affairs.
Dr. Yerian graduated from the University of Chicago-Pritzker School of Medicine. She completed residency in anatomic pathology and fellowship in gastrointestinal and liver pathology also at the University of Chicago-Pritzker School of Medicine. Dr. Yerian also completed the Harvard Business School Program for Leadership Development.
Dr. Yerian has authored over 150 manuscripts, articles, and book chapters and is the recipient of multiple awards, including the Association of American Medical Colleges Clinical Care Innovation Challenge Award. She serves on multiple nonprofit boards and speaks nationally and internationally on leadership, culture and improvement.
Request Second Opinion
Get the peace of mind you deserve. When it matters most, you can count on a second opinion from the experts at Cleveland Clinic. Find answers. Feel confident. Get a Second Opinion.
Education & Board Certifications
Education
- Fellowship: University of Chicago Hospitals, 2004
- Residency: University of Chicago Hospitals, 2003
- Medical Education: University of Chicago Pritzker School of Medicine, 2000
- Undergraduate: University of Notre Dame, 1996
Board Certifications
- Anatomic Pathology: American Board of Pathology, 2004
Professional Memberships
Innovations & Patents
Research & Publications
See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.
As of 2025-12-11, Dr. Yerian has reported the financial relationships with the companies listed below.
Fiduciary Role. Dr. Yerian serves in a fiduciary capacity, such as an elected officer, director or chief medical officer, for the following companies or other entities:
- Lean Enterprise Institute, Inc.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.